STAT
JANUARY 7, 2025
The advent of the first generic GLP-1 drugs could help Medicare negotiate a lower price for the highly sought after diabetes and obesity medication semaglutide , according to experts familiar with the price-negotiation program and STAT’s review of documents from the first round of negotiations.
PharmaVoice
JANUARY 7, 2025
New formulations for under-the-skin application of drugs give pharmas another opening in a crowded market.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
JANUARY 7, 2025
Top of the morning to you, and a fine one it is, although we concede this may depend on your tolerance for frigid temperatures. Nonetheless, blue skies and a shiny sun are enveloping the Pharmalot campus, where the official mascots are hunting wildlife and we are engaged in the usual rituals — firing up the coffee kettle in order to brew a cup of stimulation (the choice today, hazelnut mocha) and foraging for items of interest.
BioPharma Dive
JANUARY 7, 2025
Denali’s medicine and a similar one from Calico Life Sciences and AbbVie were not much different than a placebo, bringing the tally of failed drugs in the innovative “Healey platform trial” to seven.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
European Pharmaceutical Review
JANUARY 7, 2025
The US Food and Drug Administration (FDA) has for the first time, issued draft guidance on using artificial intelligence (AI) intended to support a regulatory decision about a drug or biological product. The guidelines address the safety, effectiveness or quality of these medicines. FDA has previously published a discussion paper that was produced to inform its guidance on AI in pharmaceutical drug development.
pharmaphorum
JANUARY 7, 2025
Verona Pharma's plans to transform COPD treatment with recently approved Ohtuvayre look like they are on course, given early sales figures.
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
Pharma Times
JANUARY 7, 2025
OAV101 IT expands potential for type II SMA patients
pharmaphorum
JANUARY 7, 2025
A man in Louisiana has become the first recorded fatality in the US attributed to the H5N1 strain of bird flu.
PharmaVoice
JANUARY 7, 2025
How AI will further transform the business of drug discovery and development in 2025.
pharmaphorum
JANUARY 7, 2025
GSK has claimed its second breakthrough designation from the FDA for B7-H3-targeted ADC, this time in osteosarcoma.
Advertisement
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
Pharma Times
JANUARY 7, 2025
M-Trust set to improve product safety and counterfeiting solutions
Express Pharma
JANUARY 7, 2025
With pipeline approvals of varying mechanisms of action and an influx of newly diagnosed patients, the heart failure (HF) market is expected to grow at a 9.6 per cent compound annual growth rate (CAGR) from $13.5 billion in 2022 to $33.7 billion in 2032 across the seven major markets (7MM*), forecasts GlobalData. GlobalDatas report, Heart Failure: Seven-Market Drug Forecast and Market Analysis Update, reveals that the US will contribute the most to the growth of the HF market due to the higher
The Guardian - Pharmaceutical Industry
JANUARY 7, 2025
Medical advances make pills to treat Alzheimers disease viable, though challenges remain in sharing gains globally Pills that prevent Alzheimers disease or blunt its effects are on the horizon, as the fight against dementia enters a new era, experts have said. Scientific advances were on the cusp of producing medicines that could be used even in the most remote and under-resourced parts of the world, thereby democratising care, said Jeff Cummings, professor of brain science and health at the Uni
Express Pharma
JANUARY 7, 2025
The 3rd edition of Pharma Live Expo & Summit will be held from April 17 to 19, 2025, at the Bombay Exhibition Centre, Mumbai. Organised by ICEXPO Consults in collaboration with the Indian Drug Manufacturers Association (IDMA), the event is supported by, Federation of Pharmaceutical and Allied Products Merchant Exports (FPME) & Federation of Pharma Entrepreneurs (FOPE) along with key industry stakeholders.
Speaker: Joe Sharpe and James Carlson
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
The Pharmacist
JANUARY 7, 2025
Changes to allow hub and spoke dispensing between different legal entities are likely to come in late 2025, Community Pharmacy England (CPE) has said. But changes to supervision legislation are not imminent, although the General Pharmaceutical Society (GPhC) and the Royal Pharmaceutical Society (RPS) are expected to update their standards and guidance.
Express Pharma
JANUARY 7, 2025
In December 2024, the pharma industry reported 82 deals worth $5.2 billion, compared to the last 12-month (December 2023 to November 2024) average of 100 deals worth $16.8 billion. Goldman Sachs Asset Management, to acquire a majority stake in Synthon International Holdings BV, a company engaged in developing, manufacturing, and out-licensing complex generic medicines, for a consideration of approximately $2.1 billion; AlpInvest Partners B.V. and Sixth Street Specialty Lending, investing $945.6
Outsourcing Pharma
JANUARY 7, 2025
Denali Therapeutics' DNL343 fails to slow ALS progression in phase 2/3 trial but shows safety and offers insights for future analysis.
Express Pharma
JANUARY 7, 2025
Anil Matai, Director General, OPPI “To strengthen India’s healthcare ecosystem and drive inclusive growth, the upcoming budget must prioritise increased public spending on health initiatives. This includes expanding coverage under the Ayushman Bharat scheme to the missing middle, upgrading existing Centers of Excellence, establishing new ones, and enhancing primary healthcare infrastructure.
Advertisement
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
Drug Patent Watch
JANUARY 7, 2025
Generic drugs play a crucial role in providing affordable medication options to patients. However, many individuals still harbor misconceptions and doubts about the efficacy and safety of generic alternatives. As healthcare professionals, it’s our responsibility to educate patients about generic drugs and empower them to make informed decisions about their treatment options.
Express Pharma
JANUARY 7, 2025
Zydus Lifesciences has entered into an agreement with CVS Caremark, a CVS Health company to add Zituvio, Zituvimet and Zituvimet XR (Sitagliptin | Sitagliptin and Metformin Hydrochloride) tablets to its template formulary. CVS Caremark added Zydus Zituvio and combination products to its template formulary starting January 1, 2025. Zituvio and combination products include Zituvio (sitagliptin), Zituvimet (sitagliptin and metformin hydrochloride) and Zituvimet XR (sitagliptin and metformin hydroch
Pharmaceutical Technology
JANUARY 7, 2025
Variant has entered a multi-year research partnership with Novo Nordisk to identify new targets to treat metabolic conditions.
pharmaphorum
JANUARY 7, 2025
The FDA has placed the credibility of AI's 'context of use' in pharma development at the heart of its first guidance in this area
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
BioPharma Dive
JANUARY 7, 2025
The three-year partnership is another example of Vertex’s interest in improving on Casgevy, its CRISPR medicine for sickle cell and beta thalassemia.
PharmaTech
JANUARY 7, 2025
The final guidance is a revision of a policy that has existed in some form since at least 2009, while a separate, draft guidance will accept public comment for consideration for its final version through April 8.
pharmaphorum
JANUARY 7, 2025
The life sciences industry is in a position to help humanity, perhaps more than ever, with the introduction of generative AI (GenAI).
PharmaTech
JANUARY 7, 2025
The transaction, which was first announced in September 2024, expands Phillips Medisizes inhalation drug delivery capabilities.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Pharmaceutical Technology
JANUARY 7, 2025
The FDA has accepted for filing and priority review Sentynl Therapeutics CUTX-101 NDA for the treatment of Menkes disease.
Pharmacy Times
JANUARY 7, 2025
Despite these concerns, experts have emphasized that the benefits of RSV vaccination outweigh potential risks for older adults, who are at heightened risk of severe RSV-related illness.
Pharmaceutical Technology
JANUARY 7, 2025
The transaction is expected to close in the first half of 2025, subject to the satisfaction of customary closing conditions.
PharmaTech
JANUARY 7, 2025
Webinar Date/Time: Wed, Feb 5, 2025 11:00 AM EST
Pharmaceutical Technology
JANUARY 7, 2025
Candid plans to conduct first-in-human studies in 2026 as it continues its T-cell engager deal drive.
Expert insights. Personalized for you.
325 
Let's personalize your content